Pathophysiology of dyspnea evaluated by breath-holding test: Studies of furosemide treatment

Respiratory Physiology and Neurobiology

Volumn 167, Issue 1, 2009, Pages 20-25

  Nishino, Takashi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Breath holding; Dyspnea; Furosemide

Indexed keywords

FUROSEMIDE; PLACEBO;

ARTICLE; BREATH HOLDING; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EVALUATION; EXPERIMENTAL MODEL; HUMAN; LUNG FUNCTION TEST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSATION; STIMULUS;

ANIMALS; DYSPNEA; FUROSEMIDE; HUMANS; RESPIRATION; SENSATION; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 67349233567     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2008.11.007     Document Type: Article

References (28)

1. Bianco S.M., Pieroni G., Fefini R.M., Rattoli L., and Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N. Engl. J. Med. 321 (1989) 1069-1073
2. Boggs D.F., and Bartlett Jr. D. Chemical specificity of a laryngeal apneic reflex in puppies. J. Appl. Physiol. 53 (1982) 455-462
3. Chen Z., Eldridge F.L., and Wagner P.G. Respiratory-associated rhythmic firing of midbrain neurons in cats: relation to level of respiratory drive. J. Physiol. 437 (1991) 305-325
4. Chen Z., Eldridge F.L., and Wagner P.G. Respiratory-associated thalamic activity is related to level of respiratory drive. Respir. Physiol. 90 (1992) 99-113
5. Chung K.F., and Barnes P.J. Loop diuretics and asthma. Pulm. Pharmacol. 5 (1992) 1-7
6. Gandevia S.C. Roles for perceived voluntary motor commands in motor controls. Trends Neurosci. 10 (1987) 81-85
7. Ide T., Sakurai Y., and Nishino T. Minimum alveolar anesthetic concentrations for airway occlusion in cats: a new concept of minimum alveolar anesthetic concentration-airway occlusion response. Analg. Anesth. 86 (1998) 191-197
8. Ide T., Okitsu Y., Nehashi S., Yamamoto F., and Nishino T. The effect of epidural anesthesia on respiratory distress induced by airway occlusion in isoflurane-anesthetized cats. Anesth. Analg. 92 (2001) 749-754
9. Jensen D., Amjadi K., Harris-McAllister V., Webb K.A., and O'Donnell D.E. Mechanisms of dyspnea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax 63 (2008) 606-613
10. Killian K.J., and Campbell E.J.M. Dyspnea. In: Crystal R.G., and West J.B. (Eds). The Lung (1997), Lippincott-Raven Publication, Philadelphia pp. 1986-1881
11. Kohara H., Ueoka H., Aoe K., Maeda T., Takeyama H., Saito R., Shima Y., and Uchitomi Y. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J. Pain Symptom Manage. 26 (2003) 962-967
12. Manning H.L., and Schwartzstein R.M. Pathophysiology of dyspnea. N. Eng. J. Med. 333 (1995) 1547-1553
13. Matsumoto S., Takahashi T., Tanimoto T., Saiki C., Takeda M., and Ojima K. Excitatory mechanism of veratridine on slowly adapting pulmonary stretch receptors in anesthetized rabbits. Life Sci. 64 (1998) 1431-1437
14. 2 ventilatory responsiveness in humans. Pulm. Pharmacol. Ther. 15 (2002) 363-368
15. Nehashi S., Nishino T., and Ide T. Inhaled furosemide inhibits behavioral response to airway occlusion in anesthetized cats. Anesthesiology 95 (2001) 1234-1237
16. Nishino T., Sugimori K., and Ishikawa T. Changes in the period of no respiratory sensation and total breath-holding time in successive breath-holding trials. Clin. Sci. 91 (1996) 755-761
17. Nishino T., Ide T., Sudo T., and Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am. J. Respir. Crit. Care Med. 162 (2000) 1-5
18. Ong K.C., Kor A.C., Chong W.F., Earnest A., and Wang Y.T. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 169 (2004) 1028-1033
19. Robuschi M., Gambaro G., Spagnotto S., Vaghi A., and Bianco S. Inhaled furosemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulm. Pharmacol. 1 (1987) 187-191
20. Sakurai Y., Ide T., and Nishino T. The inhibitory influence of pulmonary vagal afferents on respiratory distress induced by airway occlusion in halothane-anesthetized cats. Analg. Anesth. 86 (1998) 398-402
21. Sant'Ambrogio F.B., Sant'Ambrogio G., and Anderson J.W. Effect of furosemide on the response of laryngeal receptors to low-chloride solutions. Eur. Respir. J. 6 (1993) 1151-1155
22. Schwartzstein R.M., Manning M.H.L., Weiss J.W., and Weinberger S.E. Dyspnea: a sensory experience. Lung 168 (1990) 185-199
23. Shimoyama N., and Shimoyama M. Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. J. Pain Symptom Manage. 24 (2002) 274-275
24. Stevens S.S. On the psychophysical law. Psychol. Rev. 64 (1957) 153-181
25. Sudo T., Hayashi F., and Nishino T. Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am. J. Respir. Crit. Care Med. 162 (2000) 971-975
26. Ventresca P.G., Nichol G.M., Barnes P.J., and Chung K.F. Inhaled furosemide inhibits cough induced by low-chloride solutions but not by capsaicin. Am. Rev. Respir. Dis. 142 (1990) 143-146
27. Widdicombe J.H., Nathanson I.T., and Highland E. Effects of "loop" diuretics on ion transport by dog tracheal epithelium. Am. J. Physiol. 245 (1983) C388-C396 (Cell Physiol. 14)
28. Welsh M.J. Electrolyte transport by airway epithelia. Physiol. Rev. 67 (1987) 1143-1184